BARCLAYS PLC (BCS)
NYSEFinancialsBanks - DiversifiedSnapshot 2026-09-04
$27.00+0.37%
Close 2026-09-04 · 1-day change
NYSEFinancialsBanks - DiversifiedSnapshot 2026-09-04
Broken: Primary pillar broken — Earnings per share (EPS): metric not reported.
Barclays is a strong bank with steady earnings. It expects about $31 billion in revenue this year and $3.4 in earnings per share next year. The company is gaining market share and forming partnerships that support growth. Its price is about 24% below analyst median estimates, offering potential upside.
Barclays faces risks from competition and regulatory challenges. Recent guidance cuts show some pressure on growth. If earnings or revenue fall below analyst expectations, the outlook weakens.
The market price reflects about 24% discount to analyst median estimates for the next year. Our view aligns with consensus estimates but sees risks from recent guidance cuts and competition.
Breaks if: Loss of key partnerships or market share declines
Breaks if: EPS falls below $3.4 in FY27
Breaks if: revenue falls below $31 billion in FY26
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This investment represents a moderate-risk bet in the Financials sector, which currently has a tailwind. The thesis state is insufficient due to a lack of recent financial performance history.
The market does not currently show signs of fragility, indicating that expectations are relatively stable. Valuation confidence is high, suggesting that BCS is priced in line with its peers.
Fundamentals may face challenges given the company's recent history of misses, despite a low probability of missing expectations in the near term. The overall performance will depend on how well management executes in the coming quarters.
The thesis hinges on the performance of sector bellwethers like JPM, BAC, and HSBC. If these companies continue to perform well, it could support BCS; however, any negative shifts in their performance or changes in Federal Reserve interest rate policy could weigh on BCS.
The most important moves since the prior daily snapshot.
Mixed, the news cuts both ways. Barclays appointed Ramin Naji as Managing Director for Asia Pacific. This may improve execution in healthcare and real estate advisory. However, former CEO Jes Staley's ties to Epstein could harm the bank's reputation.
as of 2026-09-04
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Over the next 1 to 3 years, BCS's performance will be closely tied to broader sector trends and management execution. Not investment advice.